<SEC-DOCUMENT>0000899243-18-007988.txt : 20180319
<SEC-HEADER>0000899243-18-007988.hdr.sgml : 20180319
<ACCEPTANCE-DATETIME>20180319172800
ACCESSION NUMBER:		0000899243-18-007988
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20180319
FILED AS OF DATE:		20180319
DATE AS OF CHANGE:		20180319

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GV 2017 GP, L.L.C.
		CENTRAL INDEX KEY:			0001733338
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		18699908

	BUSINESS ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-335-5278

	MAIL ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GV 2017, L.P.
		CENTRAL INDEX KEY:			0001733340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		18699906

	BUSINESS ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-335-5278

	MAIL ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			GV 2017 GP, L.P.
		CENTRAL INDEX KEY:			0001733339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		18699907

	BUSINESS ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-335-5278

	MAIL ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Alphabet Inc.
		CENTRAL INDEX KEY:			0001652044
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38419
		FILM NUMBER:		18699905

	BUSINESS ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		650-253-0000

	MAIL ADDRESS:	
		STREET 1:		1600 AMPHITHEATRE PARKWAY
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Arcus Biosciences, Inc.
		CENTRAL INDEX KEY:			0001724521
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473898435
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
		BUSINESS PHONE:		650-489-9000

	MAIL ADDRESS:	
		STREET 1:		3928 POINT EDEN WAY
		CITY:			HAYWARD
		STATE:			CA
		ZIP:			94545
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>doc4.xml
<DESCRIPTION>FORM 4 SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2018-03-19</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001724521</issuerCik>
        <issuerName>Arcus Biosciences, Inc.</issuerName>
        <issuerTradingSymbol>RCUS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001733338</rptOwnerCik>
            <rptOwnerName>GV 2017 GP, L.L.C.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1600 AMPHITHEATRE PARKWAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>MOUNTAIN VIEW</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94043</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001733339</rptOwnerCik>
            <rptOwnerName>GV 2017 GP, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1600 AMPHITHEATRE PARKWAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>MOUNTAIN VIEW</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94043</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001733340</rptOwnerCik>
            <rptOwnerName>GV 2017, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1600 AMPHITHEATRE PARKWAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>MOUNTAIN VIEW</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94043</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001652044</rptOwnerCik>
            <rptOwnerName>Alphabet Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>1600 AMPHITHEATRE PARKWAY</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>MOUNTAIN VIEW</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94043</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2018-03-19</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>1924474</value>
                    <footnoteId id="F1"/>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1924474</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By GV 2017, L.P.</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Series C Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F3"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2018-03-19</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>C</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>1924474</value>
                </transactionShares>
                <transactionPricePerShare>
                    <footnoteId id="F3"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F3"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1924474</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>0</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By GV 2017, L.P.</value>
                    <footnoteId id="F2"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">The total represents shares received upon conversion of shares of Series C Convertible Preferred Stock.</footnote>
        <footnote id="F2">The reported security is directly held by GV 2017, L.P. GV 2017 GP, L.P., the general partner of GV 2017, L.P., GV 2017 GP, L.L.C., the general partner of GV 2017 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2017 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Each of GV 2017 GP, L.P., GV 2017 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc. and Alphabet Inc. disclaim beneficial ownership of the shares except to the extent of any pecuniary interest therein.</footnote>
        <footnote id="F3">The reported security converted into the Issuer's Common Stock on a 1-for-1 basis automatically immediately prior to the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.</footnote>
    </footnotes>

    <remarks></remarks>

    <ownerSignature>
        <signatureName>/s/ Scott Paraker, Attorney-in-Fact</signatureName>
        <signatureDate>2018-03-19</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.1
<SEQUENCE>2
<FILENAME>attachment1.htm
<DESCRIPTION>EX-24.1 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
                               POWER OF ATTORNEY

    The undersigned, as a Section 16 reporting person of Arcus Biosciences,
Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints
each of the persons listed on Exhibit A attached hereto, signing singly, as the
undersigned's true and lawful attorney-in-fact to:

    (1) complete and execute for and on behalf of the undersigned Forms 3, 4 and
5 and other forms and all amendments thereto as such attorney-in-fact shall in
his or her discretion determined to be required or advisable pursuant to Section
16 of the Securities Exchange Act of 1934 (as amended) and the rules and
regulations promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of
securities of the Company; and

    (2) do all acts for and on behalf of the undersigned as necessary in order
to file such forms with the Securities and Exchange Commission, any securities
exchange or national association, the Company and such other person or agency as
the attorney-in-fact shall deem appropriate.

    The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with the
Securities Exchange Act of 1934 (as amended).

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9 day of March, 2018.


                                        GV 2017 GP, L.L.C.

                                        By:  /s/ Daphne M. Chang
                                        ----------------------------------------
                                        Name: Daphne M. Chang
                                        Title: Authorized Signatory


                                     EXHIBIT A
                                     ---------

                                 Jennifer Jarrett
                                   Carolyn Tang
                                  Marcia A. Hatch
                                    Heidi Mayon
                                   Colin Conklin
                                   Scott Paraker







</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.2
<SEQUENCE>3
<FILENAME>attachment2.htm
<DESCRIPTION>EX-24.2 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
                               POWER OF ATTORNEY

    The undersigned, as a Section 16 reporting person of Arcus Biosciences,
Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints
each of the persons listed on Exhibit A attached hereto, signing singly, as the
undersigned's true and lawful attorney-in-fact to:

    (1) complete and execute for and on behalf of the undersigned Forms 3, 4 and
5 and other forms and all amendments thereto as such attorney-in-fact shall in
his or her discretion determined to be required or advisable pursuant to Section
16 of the Securities Exchange Act of 1934 (as amended) and the rules and
regulations promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of
securities of the Company; and

    (2) do all acts for and on behalf of the undersigned as necessary in order
to file such forms with the Securities and Exchange Commission, any securities
exchange or national association, the Company and such other person or agency as
the attorney-in-fact shall deem appropriate.

    The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with the
Securities Exchange Act of 1934 (as amended).

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9 day of March, 2018.


                                        GV 2017 GP, L.P.
                                        By: GV 2017 GP, L.L.C.

                                        By:  /s/ Daphne M. Chang
                                        ----------------------------------------
                                        Name: Daphne M. Chang
                                        Title: Authorized Signatory


                                     EXHIBIT A
                                     ---------

                                 Jennifer Jarrett
                                   Carolyn Tang
                                  Marcia A. Hatch
                                    Heidi Mayon
                                   Colin Conklin
                                   Scott Paraker







</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.3
<SEQUENCE>4
<FILENAME>attachment3.htm
<DESCRIPTION>EX-24.3 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
                               POWER OF ATTORNEY

    The undersigned, as a Section 16 reporting person of Arcus Biosciences,
Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints
each of the persons listed on Exhibit A attached hereto, signing singly, as the
undersigned's true and lawful attorney-in-fact to:

    (1) complete and execute for and on behalf of the undersigned Forms 3, 4 and
5 and other forms and all amendments thereto as such attorney-in-fact shall in
his or her discretion determined to be required or advisable pursuant to Section
16 of the Securities Exchange Act of 1934 (as amended) and the rules and
regulations promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of
securities of the Company; and

    (2) do all acts for and on behalf of the undersigned as necessary in order
to file such forms with the Securities and Exchange Commission, any securities
exchange or national association, the Company and such other person or agency as
the attorney-in-fact shall deem appropriate.

    The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with the
Securities Exchange Act of 1934 (as amended).

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9 day of March, 2018.


                                        GV 2017, L.P.
                                        By: GV 2017 GP, L.P.
                                        By: GV 2017 GP, L.L.C.


                                        By:  /s/ Daphne M. Chang
                                        ----------------------------------------
                                        Name: Daphne M. Chang
                                        Title: Authorized Signatory


                                     EXHIBIT A
                                     ---------

                                 Jennifer Jarrett
                                   Carolyn Tang
                                  Marcia A. Hatch
                                    Heidi Mayon
                                   Colin Conklin
                                   Scott Paraker







</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.4
<SEQUENCE>5
<FILENAME>attachment4.htm
<DESCRIPTION>EX-24.4 DOCUMENT
<TEXT>
<HTML>
<HEAD>
</HEAD>
<BODY>
<PRE>
                               POWER OF ATTORNEY

    The undersigned, as a Section 16 reporting person of Arcus Biosciences,
Inc., a Delaware corporation (the "Company"), hereby constitutes and appoints
each of the persons listed on Exhibit A attached hereto, signing singly, as the
undersigned's true and lawful attorney-in-fact to:

    (1) complete and execute for and on behalf of the undersigned Forms 3, 4 and
5 and other forms and all amendments thereto as such attorney-in-fact shall in
his or her discretion determined to be required or advisable pursuant to Section
16 of the Securities Exchange Act of 1934 (as amended) and the rules and
regulations promulgated thereunder, or any successor laws and regulations, as a
consequence of the undersigned's ownership, acquisition or disposition of
securities of the Company; and

    (2) do all acts for and on behalf of the undersigned as necessary in order
to file such forms with the Securities and Exchange Commission, any securities
exchange or national association, the Company and such other person or agency as
the attorney-in-fact shall deem appropriate.

    The undersigned hereby ratifies and confirms all that said attorneys-in-fact
and agents shall do or cause to be done by virtue hereof.  The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity
at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned's responsibilities to comply with the
Securities Exchange Act of 1934 (as amended).

    This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

    IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 9 day of March, 2018.


                                        Alphabet Inc.

                                        By:  /s/ Kent Walker
                                        ----------------------------------------
                                        Name: Kent Walker
                                        Title: Assistant Secretary


                                     EXHIBIT A
                                     ---------

                                 Jennifer Jarrett
                                   Carolyn Tang
                                  Marcia A. Hatch
                                    Heidi Mayon
                                   Colin Conklin
                                   Scott Paraker







</PRE>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
